MORF-057 Capsule clinical trials

A Phase 2a, Open-label, Single-arm Study to Evaluate the Efficacy, Safety, and Tolerability of MORF-057 in Adults with Moderately to Severely Active Ulcerative Colitis (EMERALD-1)

This study is testing a new medicine, MORF-057, for adults with ulcerative colitis that is active. Researchers want to see if it helps improve their symptoms and body changes, how safe it is, and if people can tolerate it well over 12 weeks.